Navigation Links
United Therapeutics Corporation Reports Third Quarter 2013 Financial Results
Date:10/29/2013

SILVER SPRING, Md., Oct. 29, 2013 /PRNewswire/ --

  • Revenues of $302.2 million
  • Earnings per Share of $1.25 per Basic Share or $1.17 per Diluted Share
  • Non-GAAP Earnings of $2.98 per Basic Share or $2.78 per Diluted Share
  • Raising Revenue Guidance for 2013 to Above $1.05 billion
  • United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the third quarter ended September 30, 2013.

    "I am extremely pleased with the results of the third quarter," remarked Martine Rothblatt, Ph.D., United Therapeutics' Chairman and Chief Executive Officer. "Our medicines are now prescribed for more PAH patients in the United States than any other company."

    Total net revenues for the quarter ended September 30, 2013 were $302.2 million, up from $242.5 million for the quarter ended September 30, 2012. Gross margin from sales was $269.3 million for the quarter ended September 30, 2013, compared to $212.9 million for the same quarter last year. Net income for the quarter ended September 30, 2013 was $62.7 million or $1.25 per basic share, compared to $78.1 million or $1.52 per basic share for the same quarter in 2012.

    Non-GAAP earnings(1) for the quarter ended September 30, 2013 were $149.3 million, compared to $120.6 million for the same quarter in 2012.

    ________________________ (1) 

    See definition of non-GAAP earnings, a non-GAAP financial measure, and a reconciliation of net income to non-GAAP earnings below.Financial Results for the Three Months Ended September 30, 2013 Revenues

    The table below summarizes the components of net revenues (dollars in thousands):Three Months Ended 
    September 30,Percentage
    Change20132012Cardiopulmonary products:Remodulin

    $

    132,322$

    120,8119.5'/>"/>

    SOURCE United Therapeutics Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related biology technology :

    1. United Therapeutics Corporation to Announce Third Quarter 2013 Financial Results Before Market Open on Tuesday, October 29, 2013
    2. Bayer CropScience Supports 10th Anniversary of United Way Of The Greater Triangle’s Girls’ Leadership Development Initiative
    3. Bayer CropScience and MS Technologies Receive Approval for Balance GT Soybean Technology in the United States
    4. United Therapeutics Corporation Reports Second Quarter 2013 Financial Results
    5. United Therapeutics Corporation to Announce Second Quarter 2013 Financial Results Before Market Open on Thursday, July 25, 2013
    6. Before the Bell Scans: Pharmacyclics, United Therapeutics, Impax Laboratories, and Star Scientific
    7. Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol"
    8. Centre for Sight First in the United Kingdom to Utilize TrueVision® 3D Visualization During Femtosecond Laser Cataract Surgery
    9. Prevagen® is the Number One Branded Memory Supplement in the United States
    10. SPIE on Global Team Proposing ‘international Year of Light’ at United Nations
    11. United Airlines and AltAir Fuels to Bring Commercial-Scale, Cost-Competitive Biofuels to Aviation Industry
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/19/2014)... One of the major limitations in ... vascular supply. Nutrient and gas transport throughout synthetic ... for successful regeneration and integration into the patient’s ... vascularization and promote angiogenesis in a variety of ... and architecture, and enhancing scaffolds with stem cells. ...
    (Date:8/19/2014)... (PRWEB) August 19, 2014 ... to raise $200,000 to fund a corporate lab ... , This development is a critical component ... of care to the implementation of personalized medicine ... of practicing medicine. , Indiegogo contributions will support ...
    (Date:8/19/2014)... 2014 Research and Markets ... "Spectroscopy Equipment and Accessories - Global ... offering. This report analyzes ... Accessories in US$ Thousands by the following ... Spectrometers, NMR-EPR Spectrometers, Near Infrared (NIR) Spectrometers, ...
    (Date:8/19/2014)... - iCo Therapeutics Inc. ("iCo" or "the Company") (TSX-V: ... Oral Amphotericin B (Oral Amp B) drug candidate ... ImmuneCarta®, the immune monitoring business unit of Caprion, ... Amp B in reactivating latent HIV viral reservoirs ... with antiretroviral therapy. Memory cells, ...
    Breaking Biology Technology:Vascularization in Tissue Engineering Highlighted at 12th New Jersey Symposium on Biomaterials Science 2Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 2Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 3Global Spectroscopy Equipment and Accessories - Strategic Business Report 2014 2iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 2iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 3
    ... approves Intercell,s first marketed product, a new vaccine against ... product launch in the U.S. planned for Q2 2009VIENNA, ... that the U.S. Food and Drug Administration (FDA) approved ... Encephalitis (JE). The initial target for use of Intercell,s ...
    ... Mylan Inc. (Nasdaq: MYL ) today ... which it holds a 71.2% controlling interest, has received ... Drug Administration (FDA) under the President,s Emergency Plan for ... (ANDA) for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 200 ...
    ... WALTHAM, Mass., March 30 Inverness Medical Innovations, Inc. (NYSE: ... to take charge of their health at home through the ... dividend of $3.00 per share on its Series B Convertible ... in shares of Series B stock in an amount per ...
    Cached Biology Technology:Intercell Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis 2Intercell Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis 3Intercell Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis 4Mylan's Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R) 2
    (Date:8/20/2014)... at Huntsman Cancer Institute (HCI) at the University of ... gene that encodes BCR-ABL, the unregulated enzyme driving the ... American Cancer Society, nearly 6,000 new cases of CML ... use, called tyrosine kinase inhibitors (TKIs), target BCR-ABL and ... cure CML but control it in a way that ...
    (Date:8/20/2014)... fires are visible in in this image of the ... of these were most likely intentionally set in order ... a forest or stand of trees where the land ... deforestation include conversion of forestland to farms, ranches, or ... dark green of the Amazon Rainforest in the middle ...
    (Date:8/20/2014)... Research UK scientists have discovered that acral melanomas the ... Marley,s death are genetically distinct from other more common ... external) published in the journal Pigment Cell & Melanoma ... of the hands, soles of the feet, nail-beds and other ... of melanoma, it,s not caused by UV damage from the ...
    Breaking Biology News(10 mins):Blueprint for next generation of chronic myeloid leukemia treatment 2Scientists learn more about rare skin cancer that killed Bob Marley 2
    ... Increasing block-rate water budgets are an innovative type ... block sizes are based on household characteristics, environmental conditions, ... to what constitutes "efficient" water use given those characteristics ... set relatively low for the most essential uses of ...
    ... the most serious are poverty, the growing demand for ... to satisfy the growing demand for wood, forestry in ... the Russian Federation are the world,s largest reserve of ... will result in increasing availability of wood for material ...
    ... of data related to climate change are being compiled ... these many and various sources results in different climate ... data sets to arrive at a consensus regarding future ... December in the SIAM Journal on Uncertainty Quantification ...
    Cached Biology News:An innovative approach to promote water use efficiency 2An innovative approach to promote water use efficiency 3Sustainable use of energy wood resources shows potential in North-West Russia 2Sustainable use of energy wood resources shows potential in North-West Russia 3Statistics research could build consensus around climate predictions 2Statistics research could build consensus around climate predictions 3Statistics research could build consensus around climate predictions 4
    ... Kit is intended for quantitative detection of ... which can result from the gradual, nonenzymatic ... acid residues during storage or handling. Because ... monitoring of charge differences for detection, charge ...
    ...
    ... siRNA and miRNA Isolation Traditional mRNA ... mRNA and can result in the loss ... mirVana miRNA Isolation Kit purifies all RNA ... double-stranded. Through an enrichment procedure included in ...
    ABI Plant AFLP Kits • EcoRI-ACA AFLP Amplification Primers...
    Biology Products: